🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00773J202 (prev. 00773J103 )
- Market Cap
- Small Cap
- IPO
- 4/6/2016 · $10.00/share
- Previous Symbol
- AGLE (changed 11/15/2023)
- Previous Name
- Aeglea BioTherapeutics, Inc.
Business: Spyre Therapeutics, Inc. is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection.
Company Contact
- CEO
- Cameron Turtle
- CFO
- Scott Burrows
- Headquarters
- 221 Crescent Street, Building 23, Suite 105, Waltham, MA 02453
- Phone
- 617-651-5940
- Fax
- 512-872-5121
- Investor Relations
- Eric McIntyre · eric.mcintyre@spyre.com